Considering IL‐17 is a critical cytokine initiating chronic inflammation that can affect the therapeutic responses of cancer cells, we further determined the effects of NPC‐Exos‐induced γδT‐17 cells on NPC radiotherapy. The gene discussed is IL17A; the disease is nasopharyngeal carcinoma.